Essential Biomarkers Every Executive Should Track
Beyond the Standard Physical
The standard annual physical examination was designed for population-level screening, not for optimizing individual performance and longevity. A typical panel includes a basic metabolic panel, CBC, and lipid panel — but these miss critical markers that provide early warning of metabolic dysfunction, cardiovascular risk, and hormonal imbalance years before they manifest as disease.
An executive-level biomarker panel should include four categories: metabolic health (fasting insulin, HbA1c, fasting glucose, HOMA-IR), cardiovascular risk (ApoB, Lp(a), hs-CRP, coronary artery calcium score), hormonal status (free and total testosterone, DHEA-S, thyroid panel including free T3/T4 and reverse T3), and inflammatory markers (hs-CRP, homocysteine, fibrinogen, IL-6).
ApoB is the single best predictor of cardiovascular risk — superior to LDL-C, total cholesterol, or any standard lipid metric. Each ApoB particle can penetrate the arterial wall and initiate atherosclerosis. The ideal ApoB level for longevity is below 60 mg/dL, though most standard labs do not flag levels below 90 mg/dL.
Metabolic Biomarkers in Depth
Fasting insulin is perhaps the most underutilized biomarker in conventional medicine. Insulin resistance can be detected 10-15 years before fasting glucose becomes abnormal, providing an enormous window for intervention. The HOMA-IR score (calculated as fasting glucose × fasting insulin / 405) provides a simple proxy for insulin sensitivity. Optimal is below 1.0; above 2.5 suggests significant insulin resistance.
Lipoprotein(a), or Lp(a), is a genetically determined cardiovascular risk factor present in approximately 20% of the population at elevated levels. Unlike LDL-C, Lp(a) is largely unresponsive to diet and exercise. Levels above 50 mg/dL (or 125 nmol/L) are associated with a 2-3x increased cardiovascular risk. Because it is 90% genetically determined, you only need to test it once — but that single test can fundamentally change your risk management strategy.
Do not accept "normal" lab results without examining optimal ranges. A fasting glucose of 99 mg/dL is "normal" but already indicates prediabetic metabolic trajectory. The difference between normal and optimal ranges is where preventive medicine creates its greatest value.
Which biomarker is considered the single best predictor of cardiovascular risk?
What is the approximate HOMA-IR threshold that suggests significant insulin resistance?
Curious about your diagnostics markers?
Go beyond theory. Book a comprehensive diagnostic package to measure the biomarkers discussed in this article.
Explore Diagnostic Packages